Results
1 -
10 of
11M. Liu, J. R. Ruble and S. K. Arora.
Anticancer agent chloroquinoxaline sulfonamide, Acta Cryst. (1994). C50, 2032-2033Â Â Â Â Issa Doaa A. E., Habib Nargues S., Abdel Wahab Abeer E..
Design, synthesis and biological evaluation of novel 1,2,4-triazolo and 1,2,4-triazino[4,3-a]quinoxalines as potential anticancer and antimicrobial agents, Med. Chem. Commun., 2015 Synthesis of quinoxalines and pyrido[2,3-b]pyrazines by Suzukiu2013Miyaura cross-coupling reaction, Research on Chemical Intermediates Uehara et al.
Selective degradation of splicing factor CAPERalpha by anticancer sulfonamides.
Nature Chemical Biology, doi: 10.1038/nchembio.2363, published online 24 April 2017 Phase I trial of chloroguinoxaline sulfonamide, with correlation of its pharmacokinetics and pharmacodynamics, Cancer Chemotherapy and Pharmacology Clinical and pharmacology study of chloroquinoxaline sulfonamide given on a weekly schedule, Cancer Chemotherapy and Pharmacology Chloroquinoxaline sulfonamide: A sulfanilamide antitumor agent entering clinical trials, Investigational New Drugs Evaluation ofin vitro drug screening leads using experimental models of human ovarian cancer, Investigational New Drugs Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer, Cancer Chemotherapy and Pharmacology A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC), Investigational New Drugs